Induced Myelosuppression and Recommendation for Monitoring of Absolute Neutrophil Counts in Patients Treated with Epirubicin and Cyclophosphamide in Early Breast Cancer: Results from a Phase 2a Collaborative Trial of the AGO-B and CESAR Study Groups - Pleimes, Dirk; Möbus, Volker; Mayer, Frank; Schmidt, Marcus; Asang, Corinna; Flunkert, Kathrin; Mikus, Gerd (Blood, 2018)